Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration

Area of Science:

• Ophthalmology
• Genetics
• Immunology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly.
• Complement system dysregulation, influenced by genetic factors like CFH and LOC387715 polymorphisms, is implicated in AMD pathogenesis.
• Previous studies suggested a protective role for certain complement factor B (CFB) and complement component 2 (CC2) gene variants in AMD.

Purpose of the Study:

• To validate the association between CFB and CC2 gene polymorphisms and reduced AMD susceptibility.
• To investigate the protective effects of specific single-nucleotide polymorphisms (SNPs) in CFB and CC2 in independent Caucasian cohorts.

Main Methods:

• Genotyping of two CC2 SNPs and four CFB SNPs in family-based and case-control Caucasian datasets.
• Statistical analysis to assess the association between identified SNPs and AMD risk.
• Conditional analyses and linkage disequilibrium assessments to determine independent genetic effects.

Main Results:

• The CFB R32Q variant showed significant protection against AMD in family-based data (P = 0.025).
• Three SNPs (CC2 E318D, CC2 rs547154, and CFB R32Q) were strongly associated with decreased AMD risk in case-control data.
• CFB R32Q demonstrated a robust protective effect (OR 0.21, P < 10(-4)) even after controlling for known risk factors; CC2 E318D showed a weaker, independent protective effect.

Conclusions:

• Specific polymorphisms in the CFB (R32Q) and CC2 (rs547154, E318D) genes are associated with a decreased risk of developing age-related macular degeneration.
• These findings reinforce the role of the complement system in AMD pathogenesis and highlight potential genetic biomarkers for risk assessment.